Di Salvatore, Mariantonietta
 Distribuzione geografica
Continente #
EU - Europa 542
NA - Nord America 331
AS - Asia 113
AF - Africa 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 992
Nazione #
US - Stati Uniti d'America 328
DE - Germania 302
SE - Svezia 77
IT - Italia 69
SG - Singapore 41
CN - Cina 39
GB - Regno Unito 21
UA - Ucraina 18
IE - Irlanda 17
FI - Finlandia 13
ID - Indonesia 12
TR - Turchia 9
FR - Francia 8
RU - Federazione Russa 8
IN - India 6
CI - Costa d'Avorio 4
CA - Canada 3
CZ - Repubblica Ceca 3
IR - Iran 2
NL - Olanda 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AT - Austria 1
BE - Belgio 1
ES - Italia 1
EU - Europa 1
HK - Hong Kong 1
IL - Israele 1
JP - Giappone 1
KR - Corea 1
LT - Lituania 1
Totale 992
Città #
Chandler 88
Singapore 32
New York 27
Ashburn 24
Rome 22
Dublin 17
Nürnberg 17
Nanjing 13
Jacksonville 12
Jakarta 12
Wilmington 12
San Mateo 9
Boston 8
Izmir 8
Cattolica 7
Milan 7
Woodbridge 7
Falls Church 6
Helsinki 6
Princeton 6
Boardman 5
Marseille 5
Moscow 5
Abidjan 4
Dearborn 4
Fremont 4
Lappeenranta 4
Nanchang 4
Brno 3
Falkenstein 3
Florence 3
Frankfurt am Main 3
Houston 3
Lawrence 3
London 3
Los Angeles 3
Munich 3
Redwood City 3
Santa Clara 3
Toronto 3
Alexandria 2
Ann Arbor 2
Augusta 2
Bremen 2
Fairfield 2
Hebei 2
Isorella 2
Legnano 2
Mountain View 2
Verdellino 2
Acton 1
Anzio 1
Brussels 1
Busto Arsizio 1
Büdelsdorf 1
Changsha 1
Charleston 1
Chicago 1
Cupertino 1
Fuzhou 1
Haikou 1
Hangzhou 1
Henderson 1
Hounslow 1
Indiana 1
Kish 1
Kocaeli 1
Kunming 1
Lancaster 1
Lanzhou 1
Leawood 1
Monmouth Junction 1
Paris 1
Potenza 1
Pune 1
Sacramento 1
Seattle 1
Seoul 1
Tettnang 1
University Park 1
Valencia 1
Vienna 1
Washington 1
Zanjan 1
Totale 465
Nome #
Is there a role for IGF1R and c-MET pathways in resistance to cetuximab in metastatic colorectal cancer? 251
KRAS mutational status affects oxaliplatin-based chemotherapy independently from basal mRNA ERCC-1 expression in metastatic colorectal cancer patients 182
Association of IL-8 and eNOS polymorphisms with clinical outcomes in bevacizumab-treated breast cancer patients: an exploratory analysis 150
IL-8 and eNOS polymorphisms predict bevacizumab-based first line treatment outcomes in RAS mutant metastatic colorectal cancer patients 77
Body composition changes in gastric cancer patients during preoperative flot therapy: Preliminary results of an italian cohort study 76
Let‐7a‐5p, mir‐100‐5p, mir‐101‐3p, and mir‐199a‐3p hyperexpression as potential predictive biomarkers in early breast cancer patients 59
Successful "on- demand" plerixafor for autologous peripheral blood stem-cells transplantation for relapsed/refractory germ cell tumors. 49
Mutational status of plasma exosomal KRAS predicts outcome in patients with metastatic colorectal cancer 49
Mutational status of plasma exosomal KRAS predicts outcome in patients with metastatic colorectal cancer 36
Symptomatic androgen deficiency and sexual dysfunctions in male patients receiving alectinib for ALK-positive advanced nonsmall cell lung cancer 25
Leptin-mediated meta-inflammation may provide survival benefit in patients receiving maintenance immunotherapy for extensive-stage small cell lung cancer (ES-SCLC) 22
Impact of Comprehensive Genome Profiling on the Management of Advanced Non–Small Cell Lung Cancer: Preliminary Results From the Lung Cancer Cohort of the FPG500 Program 18
Oncological Frontiers in the Treatment of Malignant Pleural Mesothelioma 15
Totale 1.009
Categoria #
all - tutte 4.235
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.235


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202066 0 0 0 0 13 11 12 3 3 8 12 4
2020/202137 0 3 3 4 4 3 4 1 4 3 8 0
2021/2022105 2 3 5 14 1 10 1 12 9 4 20 24
2022/2023221 29 35 13 34 17 19 12 28 22 1 9 2
2023/2024152 4 30 5 7 5 28 18 6 2 8 15 24
2024/202593 6 8 28 30 21 0 0 0 0 0 0 0
Totale 1.009